Egypt vs Togo: Population requiring preventive chemotherapy for schistosomiasis
Egypt
2.98 million
in 2023
Togo
3.19 million
in 2024
Egypt rank
26th
Togo rank
25th
Population requiring preventive chemotherapy for schistosomiasis over time
- Egypt
- Togo
How they compare
Togo currently reports 3.19 million against 2.98 million in Egypt, a difference of 215,180.
That makes Togo's figure about 1.1 times Egypt's.
The two have swapped places 3 times across 14 shared years of data; in 2010 it was Togo ahead.
Egypt ranks 26th and Togo ranks 25th of 52 countries.
Togo has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Egypt | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.76 million | 2.69 million | 924,240 | Togo |
| 2020s | 2.94 million | 3.44 million | 499,888 | Togo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Egypt or Togo?
- Togo, at 3.19 million against 2.98 million in Egypt as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Egypt and Togo?
- 215,180, with Togo ahead.
- How many years of comparable data are there for Egypt and Togo?
- 14 years are reported by both, from 2010 to 2023.
- How do Egypt and Togo rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Egypt ranks 26th and Togo ranks 25th of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.